Study of Blood Leptin Levels before and After Treatment with Metformin in Diabetes Type Ii Patients

• Main Authors: R Didehdar, M Afkhami - Ardekani, J Mohiti
• Format: Article
• Language: fas
• Published: Shahid Sadoughi University of Medical Sciences 2005-04-01
• Series: Majallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Shahīd Ṣadūqī Yazd
• Subjects: leptin; insulin; type II diabetes (NIDDM); Metformin.
• Online Access: http://jssu.ssu.ac.ir/browse.php?a_id=1344&slc_lang=en&sid=1&ftxt=1

Introduction: Leptin is a fat tissue hormone that has 176 amino acids with a molecular weight of 16 KD . Leptin has effects on the hypothalamus and peripheral tissues resulting in decreased food absorption and increased energy consumption that finally reduces the body weight and BMI. The aim of this research was to investigate the blood levels of leptin before and after treatment with Metformin in type II diabetic patients. Methods: 25 type II diabetic patients without any previous drug treatment history were investigated. This study was a clinical trail before and after treatment with Metformin. Results: There was no particular difference in BMI, average body weight, fat mass and free fat mass before and after treatment. Similarly, the difference in concentration levels of blood glucose, cholesterol, tri-glycerides and LDL-cholesterol before and after treatment was not statistically significant. Also, there was no difference in the average concentration of leptin and insulin before and after treatment Conclusion: This result showed that although metformin decreased glucose and lipid levels during the treatment period, (1 month) it did not have an effect on leptin, Insulin and other related factors during treatment.;